Forum Pharmaceuticals has relocated to a 112,500-square-foot facility at 225 Second Ave. in Waltham, consolidating its operations from Watertown and Brighton.

“We are excited to be located under one roof in Waltham, as it facilitates daily interaction of our development and commercial teams with research scientists to drive continued innovation in Forum’s focused product pipeline that targets serious brain diseases such as schizophrenia, Alzheimer’s and frontotemporal dementia,” said Deborah Dunsire, CEO  of Forum Pharmaceuticals, in a statement.

The property is owned by Alexandria Real Estate Equities. Robert Richards, Partner, Transwestern | RBJ represented Forum in the transaction. Building ownership was represented internally by Alexandria’s Thomas Andrews, Executive Vice President, and Dan Cordeau, Vice President of Leasing.

Forum Pharmaceuticals Moves to Alexandria Property In Waltham

by Banker & Tradesman time to read: <1 min